The DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease?
Open accessAbstract
Objective : To estimate by how much and how quickly a given reduction in serum cholesterol concentration will reduce the risk of ischaemic heart disease. Design : Data on the incidence of ischaemic heart disease and serum cholesterol concentration were analysed from 10 prospective (cohort) studies, three international studies in different communities, and 28 randomised controlled trials (with mortality data analysed according to allocated treatment to ensure the avoidance of bias). Main outcome measure - Decrease in incidence of ischaemic heart disease or mortality for a 0.6 mmol/l (about 10%) decrease in serum cholesterol concentration. Results : For men results from the cohort studies showed that a decrease of serum cholesterol concentration of 0.6 mmol/l (about 10%) was associated with a decrease in incidence of ischaemic heart disease of 54% at age 40 years, 39% at age 50, 27% at 60, 20% at 70, and 19% at 80. The combined estimate from the three international studies (for ages 55-64 years) was 38% (95% confidence interval 33% to 42%), somewhat greater than the cohort study estimate of 27%. The reductions in incidence of ischaemic heart disease in the randomised trials (for ages 55-64 years) were 7% (0 to 14%) in the first two years, 22% (15% to 28%) from 2.1-5 years, and 25% (15% to 35%) after five years, the last estimate being lose to the estimate of 27% for the long term reduction from the cohort studies. The data for women are limited but indicate a similar effect. Conclusions - The results from the cohort studies, international comparisons, and clinical trials are remarkably consistent. The cohort studies, based on half a million men and 18 000 ischaemic heart disease events, estimate that a long term reduction in serum cholesterol concentration of 0.6 mmol/l (10%), which can be achieved by moderate dietary change,lowers the risk of ischaemic heart disease by 50% at age 40, falling to 20% at age 70. The randomised trials, based on 45 000 men and 4000 ischaemic heart disease events show that the full effect of the reduction in risk is achieved by five years.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia
Frick, M. H., Elo, O., Haapa, K., Heinonen, O. P., Heinsalmi, P., Helo, P., Huttunen, J. K., Kaitaniemi, P., Koskinen, P., Manninen, V., et al. (1987) · New England Journal of Medicine · doi:10.1056/nejm198711123172001 · Cited by 3,881
Burr, M. L., Gilbert, J. F., Holliday, R. M., Elwood, P. C., Fehily, A. M., Rogers, S., Sweetnam, P. M., & Deadman, N. M. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90828-3 · Cited by 2,610
Brown, G., Albers, J. J., Fisher, L. D., Schaefer, S. M., Lin, J.-T., Kaplan, C., Zhao, X.-Q., Bisson, B. D., Fitzpatrick, V. F., & Dodge, H. T. (1990) · New England Journal of Medicine · doi:10.1056/nejm199011083231901 · Cited by 2,159
Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin
Canner, P. L., Berge, K. G., Wenger, N. K., Stamler, J., Friedman, L., Prineas, R. J., & Friedewald, W. (1986) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(86)80293-5 · Cited by 1,824
Clofibrate and Niacin in Coronary Heart Disease
(1975) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1975.03240160024021 · Cited by 1,747
Blankenhorn, D. H. (1987) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1987.03390230069027 · Cited by 1,655
Seven Countries: A Multivariate Analysis of Death and Coronary Heart Disease.
(1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-93-5-786_2 · Cited by 1,418
Martindale. The Extra Pharmacopoeia.
(1983) · Annals of Internal Medicine · doi:10.7326/0003-4819-98-5-687_2 · Cited by 1,111
EFFECT OF DIET AND SMOKING INTERVENTION ON THE INCIDENCE OF CORONARY HEART DISEASE
Hjermann, I., Holme, I., Byre, K. V., & Leren, P. (1981) · The Lancet · doi:10.1016/s0140-6736(81)91338-6 · Cited by 1,033
Buchwald, H., Varco, R. L., Matts, J. P., Long, J. M., Fitch, L. L., Campbell, G. S., Pearce, M. B., Yellin, A. E., Edmiston, W. A., Smink, R. D., et al. (1990) · New England Journal of Medicine · doi:10.1056/nejm199010043231404 · Cited by 1,001
(1978) · Journal of Chronic Diseases · doi:10.1016/0021-9681(78)90073-5 · Cited by 993
Watts, G. F., Lewis, B., Lewis, E. S., Coltart, D. J., Smith, L. D. R., Swan, A. V., Brunt, J. N. H., & Mann, J. I. (1992) · The Lancet · doi:10.1016/0140-6736(92)90863-x · Cited by 843
Lipid Research Clinics Program
Renfrew, R. A. (1984) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1984.03350180015009 · Cited by 829
Neaton, J. D. (1992) · Archives of Internal Medicine · doi:10.1001/archinte.1992.00400130082009 · Cited by 784
Carlson, L. A., & ROSENHAMER, G. (1988) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1988.tb15891.x · Cited by 677
Brensike, J. F., Levy, R. I., Kelsey, S. F., Passamani, E. R., Richardson, J. M., Loh, I. K., Stone, N. J., Aldrich, R. F., Battaglini, J. W., & Moriarty, D. J. (1984) · Circulation · doi:10.1161/01.cir.69.2.313 · Cited by 668
Keys, A. (1966) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1966.tb04737.x · Cited by 588
KATO, H., TILLOTSON, J., NICHAMAN, M. Z., RHOADS, G. G., & HAMILTON, H. B. (1973) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a121518 · Cited by 542
Chen, Z., Peto, R., Collins, R., MacMahon, S., Lu, J., & Li, W. (1991) · BMJ · doi:10.1136/bmj.303.6797.276 · Cited by 537
CONTROLLED TRIAL OF SOYA-BEAN OIL IN MYOCARDIAL INFARCTION
(1968) · The Lancet · doi:10.1016/s0140-6736(68)90746-0 · Cited by 476
Singh, R. B., Rastogi, S. S., Verma, R., Laxmi, B., Singh, R., Ghosh, S., & Niaz, M. A. (1992) · BMJ · doi:10.1136/bmj.304.6833.1015 · Cited by 458
Low-fat diet in myocardial infarction: A controlled trial.
Ball, K. P. (1965) · PubMed · Cited by 443
Bradford, R. H. (1991) · Archives of Internal Medicine · doi:10.1001/archinte.1991.00400010067008 · Cited by 372
Effect of Diet and Smoking Intervention on the Incidence of Coronary Heart Disease
Hjermann, I. (1984) · Cardiology · doi:10.1007/978-1-4757-1824-9_66 · Cited by 370
A co-operative trial in the primary prevention of ischaemic heart disease using clofibrate.
Miettinen, M., Turpeinen, O., & Karvonen, M. J. (1979) · Heart · doi:10.1136/hrt.42.3.370 · Cited by 360
Cholesterol and heart disease in older persons and women review of an NHLBI workshop
Manolio, T. A., Pearson, T. A., Wenger, N. K., Barrett-Connor, E., Payne, G. H., & Harlan, W. R. (1992) · Annals of Epidemiology · doi:10.1016/1047-2797(92)90051-q · Cited by 354
Carlson, L. A., & Rössner, S. (1978) · Atherosclerosis · doi:10.1016/0021-9150(78)90051-5 · Cited by 314
Robertson, T. L., Kato, H., Rhoads, G. G., Kagan, A., Marmot, M., Leonard Syme, S., Gordon, T., Worth, R. M., Belsky, J. L., Dock, D. S., et al. (1977) · The American Journal of Cardiology · doi:10.1016/s0002-9149(77)80197-5 · Cited by 310
Law, M. R., Wald, N. J., Wu, T., Hackshaw, A., & Bailey, A. (1994) · BMJ · doi:10.1136/bmj.308.6925.363 · Cited by 305
Self-citationHunninghake, D. B., Stein, E. A., Dujovne, C. A., Harris, W. S., Feldman, E. B., Miller, V. T., Tobert, J. A., Laskarzewski, P. M., Quiter, E., Held, J., et al. (1993) · New England Journal of Medicine · doi:10.1056/nejm199304293281701 · Cited by 295
Test of effect of lipid lowering by diet on cardiovascular risk. The Minnesota Coronary Survey.
Frantz, I. D., Dawson, E. A., Ashman, P. L., Gatewood, L. C., Bartsch, G. E., Kuba, K., & Brewer, E. R. (1989) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.9.1.129 · Cited by 293
Isles, C. G., Hole, D. J., Hawthorne, V. M., & Lever, A. F. (1992) · The Lancet · doi:10.1016/0140-6736(92)90599-x · Cited by 277
Ischaemic Heart Disease: A Secondary Prevention Trial Using Clofibrate
Research Committee of the Scottish Society of Physicians (1971) · BMJ · doi:10.1136/bmj.4.5790.775 · Cited by 242
Puska, P., Salonen, J. T., Nissinen, A., Tuomilehto, J., Vartiainen, E., Korhonen, H., Tanskanen, A., Rönnqvist, P., Koskela, K., & Huttunen, J. (1983) · BMJ · doi:10.1136/bmj.287.6408.1840 · Cited by 240
(1966) · PubMed · Cited by 218
Colestipol hydrochloride in hypercholesterolemic patients—Effect on serum cholesterol and mortality
Dorr, A. E., Gundersen, K., Schneider, J. C., Spencer, T. W., & Martin, W. B. (1978) · Journal of Chronic Diseases · doi:10.1016/0021-9681(78)90076-0 · Cited by 203
Rosengren, A., Welin, L., Tsipogianni, A., & Wilhelmsen, L. (1989) · BMJ · doi:10.1136/bmj.299.6708.1127 · Cited by 199
Corn Oil in Treatment of Ischaemic Heart Disease
Rose, G. A., Thomson, W. B., & Williams, R. T. (1965) · BMJ · doi:10.1136/bmj.1.5449.1531 · Cited by 197
A Controlled Clinical Trial of a Diet High in Unsaturated Fat: Preliminary Observations
Dayton, S., Pearce, M. L., Hashimoto, S., Fakler, L. J., Hiscock, E., & Dixon, W. J. (1962) · New England Journal of Medicine · doi:10.1056/nejm196205172662001 · Cited by 193
Low Fat, Low Cholesterol Diet in Secondary Prevention of Coronary Heart Disease
Woodhill, J. M., Palmer, A. J., Leelarthaepin, B., McGilchrist, C., & Blacket, R. B. (1978) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4684-0967-3_18 · Cited by 181
TOWARDS AN IMPROVED LIPID-LOWERING DIET: ADDITIVE EFFECTS OF CHANGES IN NUTRIENT INTAKE
Lewis, B., Katan, M., Merkx, I., Miller, N. E., Hammett, F., Kay, R. M., Nobels, A., & Swan, A. V. (1981) · The Lancet · doi:10.1016/s0140-6736(81)91339-8 · Cited by 166
Prevention of restenosis by lovastatin after successful coronary angioplasty
Sahni, R., Maniet, A. R., Voci, G., & Banka, V. S. (1991) · American Heart Journal · doi:10.1016/0002-8703(91)90002-y · Cited by 161
Multifactorial Primary Prevention of Cardiovascular Diseases in Middle-aged Men
Miettinen, T. A. (1985) · JAMA · doi:10.1001/jama.1985.03360150073027 · Cited by 157
Pocock, S., Shaper, A. G., & Phillips, A. N. (1989) · BMJ · doi:10.1136/bmj.298.6679.998 · Cited by 147
Comparison of Three Cholesterol-Lowering Diets in Normolipidemic Men
Grundy, S. M., Nix, D., Whelan, M. F., & Franklin, L. (1986) · JAMA · doi:10.1001/jama.1986.03380170067020 · Cited by 127
Shipley, M. J., Pocock, S., & Marmot, M. G. (1991) · BMJ · doi:10.1136/bmj.303.6794.89 · Cited by 112
Decline in ischaemic heart disease in Iceland and change in risk factor levels.
Sigfússon, N., Sigvaldason, H., Steingrímsdóttir, L., Gudmundsdottir, I. I., Stefansdottir, I., Thorsteinsson, T., & Sigurðsson, G. (1991) · BMJ · doi:10.1136/bmj.302.6789.1371 · Cited by 103
The Coronary Drug Project. Initial findings leading to modifications of its research protocol
(1970) · JAMA · doi:10.1001/jama.214.7.1303 · Cited by 101
Miller, G. J., Cruickshank, J. K., Ellis, L. J., Thompson, R. L., Wilkes, H., Stirling, Y., Mitropoulos, K. A., Allison, J., Fox, T. E., & Walker, A. O. (1989) · Atherosclerosis · doi:10.1016/0021-9150(89)90154-8 · Cited by 95
Frick, M. H., Heinonen, O. P., Huttunen, J. K., Koskinen, P., Mänttäri, M., & Manninen, V. (1993) · Annals of Medicine · doi:10.3109/07853899309147855 · Cited by 94
An ecological study of serum cholesterol and ischaemic heart disease between 1950 and 1990.
Law, M. R., & Wald, N. J. (1994) · PubMed · Cited by 82
Self-citationGENDER, LIPOPROTEINS, DIET, AND CARDIOVASCULAR RISK
Crouse, J. R. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91320-2 · Cited by 77
Serum Cholesterol and Mortality Among Japanese-American Men: The Honolulu (Hawaii) Heart Program
Stemmermann, G. N., Chyou, P. H., Kagan, A., Nomura, A. M., & Yano, K. (1991) · Archives of Internal Medicine · doi:10.1001/archinte.151.5.969 · Cited by 75
Orchidectomy versus oestrogen for prostatic cancer: cardiovascular effects.
Henriksson, P., & Edhag, O. (1986) · BMJ · doi:10.1136/bmj.293.6544.413 · Cited by 72
Effect of combined clofibrate-nicotinic acid treatment in ischemic heart disease An interim report
Rosenhamer, G., & Carlson, L. A. (1980) · Atherosclerosis · doi:10.1016/0021-9150(80)90100-8 · Cited by 69
Effective lipid lowering diets including lean meat
Watts, G. F., Ahmed, W., Quiney, J., Houlston, R. S., Jackson, P. G., Iles, C., & Lewis, B. (1988) · BMJ · doi:10.1136/bmj.296.6617.235 · Cited by 69
Leren, P. (1968) · Europe PMC (PubMed Central) · Cited by 65
WHO clofibrate/cholesterol trial: clarifications
Heady, J. A., Morris, J. N., & Oliver, M. F. (1992) · The Lancet · doi:10.1016/0140-6736(92)92588-7 · Cited by 60
Cholesterol and coronary heart disease mortality. A 23-year follow-up study of 9902 men in Israel.
Goldbourt, U., & Yaari, S. (1990) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.10.4.512 · Cited by 50
The U.S. Veterans Administration Cardiology Drug-Lipid Study: An Interim Report
SCHOCH, H. K. (1969) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-6866-7_34 · Cited by 37
Detre, K. M., & Shaw, L. (1974) · Circulation · doi:10.1161/01.cir.50.5.998 · Cited by 30
Running out of staff for the NHS.
Livesley, B. (1989) · BMJ · doi:10.1136/bmj.299.6690.1 · Cited by 30
LOW-FAT DIET IN MYOCARDIAL INFARCTION
Michaels, L., & Ball, K. P. (1965) · The Lancet · doi:10.1016/s0140-6736(65)90850-0 · Cited by 29
The Long-term Effects of Probucol on Serum Lipid Levels
McCaughan, D. (1981) · Archives of Internal Medicine · doi:10.1001/archinte.1981.00340120036010 · Cited by 27
Long‐Term Cholesterol‐Lowering Effect of Colestipol Resin in Humans*
Gross, L., & Figueredo, R. (1973) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1973.tb01662.x · Cited by 17
[Evaluation of clofibrate therapy in peripheral arteriopathy].
Tb, B., & Bm, R. (1971) · PubMed · Cited by 8
Cited by
Grundy, S. M., Cleeman, J. I., Merz, C. N. B., Brewer, H. B., Clark, L. T., Hunninghake, D. B., Pasternak, R. C., Smith, S. C., & Stone, N. J. (2004) · Circulation · doi:10.1161/01.cir.0000133317.49796.0e · Cited by 6,902
(1999) · Journal of Hypertension · doi:10.1097/00004872-199917020-00001 · Cited by 3,695
Selected major risk factors and global and regional burden of disease
Ezzati, M., Lopez, A. D., Rodgers, A., Vander Hoorn, S., & Murray, C. J. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11403-6 · Cited by 3,594
PEDERSEN, T. R. (2004) · Atherosclerosis Supplements · doi:10.1016/j.atherosclerosissup.2004.08.027 · Cited by 3,106
Metadata
- Authors
- Law, M. R., Wald, N. J., & Thompson, S. G.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 1994-02-05
- Volume
- 308
- Issue
- 6925
- Pages
- 367-372
- ISSN
- 0007-1447 (ISSN-L)
- 0959-8138
- 1468-5833
- OpenAlex
- W2132931461
- Cited by
- 1,210
- References
- 70
- FWCI
- 79.44
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.